7. TRACHOMA
The leading cause of preventable blindness in
the world
15 – 20% world’s blindness
Caused by chlamydia trachomatis A , B, Ba &
C
Self limiting disease
Repeated infections + secondary infection
blindness
13. CLINICAL FEATURES
ACTIVE STAGE
CHRONIC STAGE
COMPLICATIONS
ACTIVE
1st
decade
CHRONIC
2nd
decade
COMPLICATIONS
4th / 5th
decade
14. TRACHOMA
CONJUNCTIVA
Congestion, papillae & FOLLICLES
UPPER TARSUS
Follicles - > 5 mm in diameter
along the upper border of the upper
tarsus
NEVER ON THE BULBAR
CONJUNCTIVA
MINUTE STELLATE SCARS
HISTOPATH – aggregations of lymphocytes with
necrosis & leber cells - follicles
26. investigations
mcCoy cell cultures, monoclonal antibody test
& IgA-IPA light microscopy – best combination
CLINICAL DIAGNOSIS:
any 2 of the signs
1.follicles on the upper tarsus
2.superficial keratitis – upper k
3.pannus – upper k
4.limbal follicles/ Herbert pits
5.stellate scars/Arlt’s line – upper tarsus
27. Maccallan classification
STAGES FEATURES
I IMMATURE FOLLICLES , SPK
IIA MATURE FOLLICLES
IIB PANNUS, LIMBAL FOLLICLES, SUPERFICIAL KERATITIS
III FOLLICLES + SCARRING
IV SCARRING
28. WHO CLASSIFICATION [
FISTO]
STAGES FEATURES TREATMENT
FOLLICLES ≥5 FOLLICLES, >0.5MM IN
UPPER TARSUS
NEEDS TREATMENT
NO SCARRING
INTENSE >50% PALPEBRAL BLOOD
VESSELS NOT SEEN
UREGENT
TREATMENT
COMPLICATIONS +
SCARRING TARSAL CONJ SCARRING WITH
WHITE FIBROUS BANDS
INACTIVE
TRICHIASIS ATLEAST ONE TRICHIATIC LASH CORRECTIVE
SURGERY
OPACITIES K OPACITY COVERING
PUPILLARY REGION
29. WHO CLASSIFICATION [
FISTO]
STAGES FEATURES TREATMENT
FOLLICLES ≥5 FOLLICLES, >0.5MM IN
UPPER TARSUS
NEEDS TREATMENT
NO SCARRING
INTENSE >50% PALPEBRAL BLOOD
VESSELS NOT SEEN
UREGENT
TREATMENT
COMPLICATIONS +
SCARRING TARSAL CONJ SCARRING WITH
WHITE FIBROUS BANDS
INACTIVE
TRICHIASIS ATLEAST ONE TRICHIATIC LASH CORRECTIVE
SURGERY
OPACITIES K OPACITY COVERING
PUPILLARY REGION
30. MANAGEMENT –
PREVENTION
How will you prevent this disease ?
Manage the risk factors
Frequent face wash & hand wash
Prophylactic topical antibiotic therapy -
BLANKET THERAPY:
- In endemic areas
-1% tetracycline e/o 2 times / day –5 days a
month 6 months
31. TREATMENT – ACTIVE
STAGE
TOPICAL:
1% tetracycline / erythromycin
e/o
4 times /day 6 weeks
1% tetracycline e/o bed time6 weeks
34. TREATMENT- “nutshell”
SAFE STRATEGY
S – surgery for trichiasis & entropion
A – antibiotic (erythromycin)
F – face washing
E – environmental hygiene
35. Management in a community
prevalence of
trachoma in
children 1-10 yrs
treatment Eye health
promotion
TF≥20%
TI≥5%
MASS TOPICAL
IF SEVERE- SYSTEMIC
SANITATION, FLIES
CONTROL, PERSONAL
HYGIENE,AB RX
DURING OUTBREAKS
TF 5-20% MASS TOPICAL
IF SEVERE -
SYSTEMIC
AS ABOVE
TF< 5% INDIVIDUAL TOPICAL
RX
CASE FINDING
46. FUNGAL CONJUNCTIVITIS
By aspergillus, candida, nocardia, leptothrix,
sporothrix
Modes of presentation:
Follicular conjunctivitis with lymphadenopathy
Ulcerative / pseudomembranous
Granulomatous actinomycosis,
sporotrichosis, rhinosporidiosis
Rx : topical miconazole or clotrimazole 1%
47. NON SPECIFIC
CONJUNCTIVITIS
Continuation of simple conjunctivitis
Chronic irritation: smoke, dust, heat, alcohol
abuse,etc
Hypersensitivity to allergen
Concretion, trichiasis, blepharitis,
dacryocystitis, chronic rhinitis
Symptoms:
burning & grittiness ^^ in the evening
48. Non specific conjunctivitis
Signs: lower lid congestion
sticky mucous membrane
Rx:
Short course of antibiotics
Eliminate the cause
Lubricants